Pfizer requested emergency approval for its vaccine in India

Pfizer requested emergency approval for its vaccine in India

At the moment the country is the second in the world by the number of infected with coronavirus.

Pfizer has applied for emergency Coronavirus vaccine approval in India. The country is ranked second in the world by the number of cases of infection.

Advisor to the Government of India on Coronavirus V.K. Paul noted that usually the Indian drug regulator reviews the issues of vaccine approval within 90 days, but in this situation the process can go faster.

It is not yet known how much Pfizer will deliver its vaccine to India. The main problem in this regard is the lack of conditions for vaccine storage in many refrigeration plants. The vaccine should be stored at -70 degrees Celsius.

At the same time, the country hopes to supply five COVID-19 vaccines that have been tested in the country. They also include a sample developed by Oxford University and Astrazeneca.

India has recorded 9.57 million cases of infection throughout the Coronavirus pandemic, the second highest in the world after the United States. Also in the country, 140.5 thousand people died from COVID-19.